Colorectal Cancer Triage Test
Detects the cfDNA concentration of the FIT-positive patients and further stratifies the risk for Colorectal Cancer.
Research Service
Introducing Colorectal Cancer Triage Test
Colorectal cancer (CRC) is the second cause of cancer death in the U.S. The age of getting colorectal cancer is getting younger. American Cancer Society recommends people with age 45 to 74 get a screening test for CRC. One of the most common screening test is FIT (fecal immunochemical test) or iFOB (Immunological Fecal Occult Blood) test. However, 25% of FIT-positive patients turn out to be positive. To reduce the false-positive population, the QuantiDNA™ Colorectal Cancer Triage Test detects the cfDNA concentration of the FIT-positive patients and further stratifies the risk for CRC.
Simple blood test: only 2 tubes of blood needed
Intended for Colorectal cancer risk stratification for patients tested with FIT-positive
Are your patients at risk of Colorectal Cancer?
We have developed QuantiDNA™ Colorectal Cancer Triage Test to detect the cfDNA concentration of the FIT-positive patients and further stratifies the risk for CRC.
%
The 5-year survival rate for patients diagnosed with localized stage of Colorectal Cancer
%
The 5-year survival rate for patients diagnosed at a distant stage
The DiaCarta Offerings
SERVICE
The QuantiDNA™ Colorectal Cancer Triage test is available at DiaCarta as a research service and a LDT testing service.
Simple blood test: only 2 tubes of blood needed
Fast turnaround time: report ready in 3-5 business days upon sample receipt
ORDER THE TEST